Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ANB020
ANB020
AnaptysBio plans phase 2b peanut allergy trial after taking positives from POC data
Fierce Biotech
Tue, 03/27/18 - 09:52 am
AnaptysBio
clinical trials
peanut allergy
ANB020
2 Biotech Stocks Near All-Time Highs: Can They Keep Climbing?
Motley Fool
Mon, 03/19/18 - 11:41 am
biotech
BeiGene
China
Celgene
AnaptysBio
ANB020
eczema